- Home
- BOTJ vs INZY Comparison
BOTJ vs INZY Comparison
Compare BOTJ & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOTJ
- INZY
- Stock Information
- Founded
- BOTJ 1998
- INZY 2015
- Country
- BOTJ United States
- INZY United States
- Employees
- BOTJ N/A
- INZY N/A
- Industry
- BOTJ Major Banks
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- BOTJ Finance
- INZY Health Care
- Exchange
- BOTJ Nasdaq
- INZY Nasdaq
- Market Cap
- BOTJ 63.5M
- INZY 64.9M
- IPO Year
- BOTJ N/A
- INZY 2020
- Fundamental
- Price
- BOTJ $14.10
- INZY $1.20
- Analyst Decision
- BOTJ
- INZY Strong Buy
- Analyst Count
- BOTJ 0
- INZY 9
- Target Price
- BOTJ N/A
- INZY $17.22
- AVG Volume (30 Days)
- BOTJ 2.8K
- INZY 1.1M
- Earning Date
- BOTJ 04-30-2025
- INZY 05-20-2025
- Dividend Yield
- BOTJ 2.79%
- INZY N/A
- EPS Growth
- BOTJ N/A
- INZY N/A
- EPS
- BOTJ 1.45
- INZY N/A
- Revenue
- BOTJ $45,083,000.00
- INZY N/A
- Revenue This Year
- BOTJ N/A
- INZY N/A
- Revenue Next Year
- BOTJ N/A
- INZY N/A
- P/E Ratio
- BOTJ $9.79
- INZY N/A
- Revenue Growth
- BOTJ 4.72
- INZY N/A
- 52 Week Low
- BOTJ $10.14
- INZY $0.72
- 52 Week High
- BOTJ $17.05
- INZY $6.24
- Technical
- Relative Strength Index (RSI)
- BOTJ 53.87
- INZY 56.87
- Support Level
- BOTJ $13.81
- INZY $1.18
- Resistance Level
- BOTJ $14.39
- INZY $1.63
- Average True Range (ATR)
- BOTJ 0.33
- INZY 0.19
- MACD
- BOTJ 0.03
- INZY 0.03
- Stochastic Oscillator
- BOTJ 74.56
- INZY 38.93
About BOTJ Bank of the James Financial Group Inc.
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.